These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34854884)

  • 21. Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice.
    Honarpisheh P; Reynolds CR; Blasco Conesa MP; Moruno Manchon JF; Putluri N; Bhattacharjee MB; Urayama A; McCullough LD; Ganesh BP
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis.
    Liao F; Hori Y; Hudry E; Bauer AQ; Jiang H; Mahan TE; Lefton KB; Zhang TJ; Dearborn JT; Kim J; Culver JP; Betensky R; Wozniak DF; Hyman BT; Holtzman DM
    J Neurosci; 2014 May; 34(21):7281-92. PubMed ID: 24849360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease.
    Chen Y; Fang L; Chen S; Zhou H; Fan Y; Lin L; Li J; Xu J; Chen Y; Ma Y; Chen Y
    Biomed Res Int; 2020; 2020():8456596. PubMed ID: 32596386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo uptake of β-amyloid by non-plaque associated microglia.
    Hawkes CA; Deng L; Fenili D; Nitz M; McLaurin J
    Curr Alzheimer Res; 2012 Oct; 9(8):890-901. PubMed ID: 22272621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.
    Manczak M; Mao P; Nakamura K; Bebbington C; Park B; Reddy PH
    Hum Mol Genet; 2009 Oct; 18(20):3876-93. PubMed ID: 19617638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.
    Zhang JD; Liu J; Zhu SW; Fang Y; Wang B; Jia Q; Hao HF; Kao JY; He QH; Song LJ; Liu F; Zhu BL; Owyang C; Duan LP
    Acta Pharmacol Sin; 2021 Nov; 42(11):1821-1833. PubMed ID: 33558654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of transcriptome remodeling in plaque-associated and plaque-distant microglia during amyloid-β pathology progression in mice.
    Hemonnot-Girard AL; Meersseman C; Pastore M; Garcia V; Linck N; Rey C; Chebbi A; Jeanneteau F; Ginsberg SD; Lachuer J; Reynes C; Rassendren F; Hirbec H
    J Neuroinflammation; 2022 Sep; 19(1):234. PubMed ID: 36153535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple factors contribute to the peripheral induction of cerebral β-amyloidosis.
    Eisele YS; Fritschi SK; Hamaguchi T; Obermüller U; Füger P; Skodras A; Schäfer C; Odenthal J; Heikenwalder M; Staufenbiel M; Jucker M
    J Neurosci; 2014 Jul; 34(31):10264-73. PubMed ID: 25080588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
    Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.
    Go M; Kou J; Lim JE; Yang J; Fukuchi KI
    Biochem Biophys Res Commun; 2016 Oct; 479(2):331-337. PubMed ID: 27641666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway.
    Lee S; Xu G; Jay TR; Bhatta S; Kim KW; Jung S; Landreth GE; Ransohoff RM; Lamb BT
    J Neurosci; 2014 Sep; 34(37):12538-46. PubMed ID: 25209291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blast-Mediated Traumatic Brain Injury Exacerbates Retinal Damage and Amyloidosis in the APPswePSENd19e Mouse Model of Alzheimer's Disease.
    Harper MM; Hedberg-Buenz A; Herlein J; Abrahamson EE; Anderson MG; Kuehn MH; Kardon RH; Poolman P; Ikonomovic MD
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2716-2725. PubMed ID: 31247112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microglial depletion and abnormalities in gut microbiota composition and short-chain fatty acids in mice after repeated administration of colony stimulating factor 1 receptor inhibitor PLX5622.
    Yang Y; Ishima T; Wan X; Wei Y; Chang L; Zhang J; Qu Y; Hashimoto K
    Eur Arch Psychiatry Clin Neurosci; 2022 Apr; 272(3):483-495. PubMed ID: 34480631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Clostridium butyricum against Microglia-Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate.
    Sun J; Xu J; Yang B; Chen K; Kong Y; Fang N; Gong T; Wang F; Ling Z; Liu J
    Mol Nutr Food Res; 2020 Jan; 64(2):e1900636. PubMed ID: 31835282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.
    Wegiel J; Wang KC; Imaki H; Rubenstein R; Wronska A; Osuchowski M; Lipinski WJ; Walker LC; LeVine H
    Neurobiol Aging; 2001; 22(1):49-61. PubMed ID: 11164276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid beta protein deposition and neuron loss in osteopetrotic (op/op) mice.
    Kaku M; Tsutsui K; Motokawa M; Kawata T; Fujita T; Kohno S; Tohma Y; Ohtani J; Tenjoh K; Tanne K
    Brain Res Brain Res Protoc; 2003 Oct; 12(2):104-8. PubMed ID: 14613812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
    Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the microbiota-Alzheimer's disease linkage using short-term antibiotic treatment followed by fecal microbiota transplantation.
    Wang M; Cao J; Gong C; Amakye WK; Yao M; Ren J
    Brain Behav Immun; 2021 Aug; 96():227-238. PubMed ID: 34111528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid Beta Pathology Exacerbates Weight Loss and Brain Cytokine Responses following Low-Dose Lipopolysaccharide in Aged Female Tg2576 Mice.
    Knopp RC; Baumann KK; Wilson ML; Banks WA; Erickson MA
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.